Skip to content
Raw material supply for functional food and supplement manufacturersRequest a sampleMember login
English

Botanical extract

MaquiBright®

Support for relieving dry eye discomfort

MaquiBright®

Technical information

TypeBotanical extract
Botanical sourceAristotelia chilensis — maqui berry

Composition

  • Standardized to contain at least 25% delphinidins and at least 35% total anthocyanins

Overview

MaquiBright® is a patented, premium maqui berry extract that is extraordinarily rich in flavonoids. It is standardized to contain at least 25% delphinidins and at least 35% total anthocyanins.

Maqui berry is a native berry that grows in Chile and has been consumed since ancient times. It is extraordinarily rich in powerful flavonoids known as anthocyanins; the delphinidin subgroup of these flavonoids is responsible for the berry’s very dark purple color and for some of its reported health effects.

It is an ingredient supported by several clinical and in vitro studies.

Applications

MaquiBright® is a highly water-soluble extract that has demonstrated significant clinical effects at low doses.

It can be used alone or in combination with other ingredients in supplements aimed at supporting eye health.

Key features

A significant 89% increase in tear production after 4 weeks has been reported.

A significant 57% reduction in bothersome eye discomfort after 4 weeks has been reported.

It supports eye health with its high antioxidant and anthocyanin content.

It helps nourish the eyes and contributes to naturally restoring normal tear production.

It is a potent antioxidant that supports the eyes’ response to oxidative stress.

It is reported to relieve eye fatigue, shoulder stiffness and temporary eye discomfort associated with prolonged screen use.

Related publication: Tanaka J. et al. “Maqui berry (Aristotelia chilensis) and the constituent delphinidin glycoside inhibit photoreceptor cell death induced by visible light.” Food Chemistry. 2013 Aug 15;139(1-4):129-37.

Mechanism of action

Maqui berry and its constituent delphinidin glycoside have been shown to inhibit photoreceptor cell death induced by visible light.

Related publication: Tanaka J. et al. Food Chemistry. 2013 Aug 15;139(1-4):129-37. doi:10.1016/j.foodchem.2013.01.036

Awards

  • 2019 NutraIngredient Award Wiiner – Product of the Year: OptiBright by Anklam Extract

Images

MaquiBright® image 1

Sample or quote for MaquiBright®

Contact our formulation team for technical documentation, sample requests and pricing.